Ultragenyx Pharmaceutical Inc. (0LIF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
64.79-58.85 (-47.60%)
As of 6:20PM GMT. Market open.
| Previous close | 123.64 |
| Open | 122.54 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 122.54 - 122.54 |
| 52-week range | 122.54 - 122.54 |
| Volume | 1 |
| Avg. volume | N/A |
| Market cap | 3.774B |
| Beta (5Y monthly) | 1.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.07 |
| Earnings date | 04 May 2021 - 10 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
- Zacks
Why Is Ultragenyx (RARE) Down 22% Since Last Earnings Report?
Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Ultragenyx's (RARE) IND for mRNA Therapy, UX053 Cleared by FDA
The FDA clears Ultragenyx's (RARE) investigational new drug application for UX053 being developed to treat Glycogen Storage Disease Type III.
© 2021 Verizon Media. All rights reserved.
